{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:49:50Z","timestamp":1740134990901,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012353","name":"german cancer consortium","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4826-3","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:04:20Z","timestamp":1537794260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms"],"prefix":"10.1186","volume":"18","author":[{"given":"Kaja","family":"Tikk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Kopp-Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"5","key":"4826_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"4826_CR2","volume-title":"Krebs in Deutschland 2011\/2012","author":"P Kaatsch","year":"2015","unstructured":"Kaatsch P, Spix C, Hentschel S, Katalinic A, Luttmann S, Stegmaier C, Caspritz S, Christ M, Ernst A, Folkerts J, et al. Krebs in Deutschland 2011\/2012. Berlin: Robert Koch Institut; 2015."},{"issue":"6","key":"4826_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1572-0241.2008.01875.x","volume":"103","author":"P Hewitson","year":"2008","unstructured":"Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"4826_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/gutjnl-2011-300774","volume":"61","author":"JH Scholefield","year":"2012","unstructured":"Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2012;61(7):1036\u201340.","journal-title":"Gut"},{"issue":"12","key":"4826_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","volume":"369","author":"A Shaukat","year":"2013","unstructured":"Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106\u201314.","journal-title":"N Engl J Med"},{"issue":"3","key":"4826_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7326\/M13-1484","volume":"160","author":"JK Lee","year":"2014","unstructured":"Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171.","journal-title":"Ann Intern Med"},{"issue":"22","key":"4826_CR7","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1001\/jama.2010.1773","volume":"304","author":"H Brenner","year":"2010","unstructured":"Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304(22):2513\u201320.","journal-title":"JAMA"},{"issue":"9","key":"4826_CR8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/ijc.30629","volume":"140","author":"H Brenner","year":"2017","unstructured":"Brenner H, Niedermaier T, Chen H. Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin. Int J Cancer. 2017;140(9):2015\u201322.","journal-title":"Int J Cancer"},{"issue":"11","key":"4826_CR9","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/gutjnl-2016-311819","volume":"66","author":"E J Grobbee","year":"2016","unstructured":"Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJC, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, et al. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening. Gut. 2017;66(11):1975-82.","journal-title":"Gut"},{"issue":"8","key":"4826_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","volume":"53","author":"F Santilli","year":"2009","unstructured":"Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \"resistance\". J Am Coll Cardiol. 2009;53(8):667\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4826_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/EJA.0b013e328335b354","volume":"27","author":"E Zisman","year":"2010","unstructured":"Zisman E, Erport A, Kohanovsky E, Ballagulah M, Cassel A, Quitt M, Pizov R. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Eur J Anaesthesiol. 2010;27(7):617\u201323.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"4826_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/jcan.2001.20277","volume":"15","author":"NM Gibbs","year":"2001","unstructured":"Gibbs NM, Weightman WM, Thackray NM, Michalopoulos N, Weidmann C. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2001;15(1):55\u20139.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"4826_CR13","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The statistical evaluation of medical tests for classification and prediction","author":"MS Pepe","year":"2003","unstructured":"Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York: Oxford University Press; 2003."},{"key":"4826_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/9780470317082","volume-title":"Statistical methods in diagnostic medicine","author":"XH Zhou","year":"2002","unstructured":"Zhou XH, Obuchowski NA, Obuchowski DM. Statistical methods in diagnostic medicine. New York: John Wiley and Sons; 2002."},{"issue":"6","key":"4826_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0049-3848(90)90123-T","volume":"59","author":"D Vanags","year":"1990","unstructured":"Vanags D, Rodgers SE, Lloyd JV, Bochner F. The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. Thromb Res. 1990;59(6):995\u20131005.","journal-title":"Thromb Res"},{"issue":"1","key":"4826_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF02591396","volume":"22","author":"EM Pogliani","year":"1992","unstructured":"Pogliani EM, Fowst C, Bregani R, Corneo G. Bleeding time and antiplatelet agents in normal volunteers. Int J Clin Lab Res. 1992;22(1):58\u201361.","journal-title":"Int J Clin Lab Res"},{"issue":"2","key":"4826_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0049-3848(97)00229-6","volume":"88","author":"JA May","year":"1997","unstructured":"May JA, Heptinstall S, Cole AT, Hawkey CJ. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. Thromb Res. 1997;88(2):183\u201392.","journal-title":"Thromb Res"},{"issue":"6","key":"4826_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s10620-010-1150-4","volume":"55","author":"MS Sawhney","year":"2010","unstructured":"Sawhney MS, McDougall H, Nelson DB, Bond JH. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci. 2010;55(6):1637\u201342.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"4826_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.amjmed.2004.05.028","volume":"117","author":"CJ Kahi","year":"2004","unstructured":"Kahi CJ, Imperiale TF. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans. Am J Med. 2004;117(11):837\u201341.","journal-title":"Am J Med"},{"issue":"4","key":"4826_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ajg.2009.14","volume":"104","author":"Z Levi","year":"2009","unstructured":"Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol. 2009;104(4):933\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"4826_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/ajg.2009.18","volume":"104","author":"TR Levin","year":"2009","unstructured":"Levin TR. Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol. 2009;104(4):939\u201341.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"4826_CR22","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s10620-010-1247-9","volume":"55","author":"DM McCarthy","year":"2010","unstructured":"McCarthy DM. Probing the occult: testing for blood in the stools. Dig Dis Sci. 2010;55(6):1503\u20135.","journal-title":"Dig Dis Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4826-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:57:43Z","timestamp":1720634263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4826-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4826"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4826-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The trial is planned and is conducted according to the principles as stated in the Declaration of Helsinki, applicable local regulations, including German drug law (AMG) and the rules for good clinical practice (ICH-GCP, GCP-V). The trial was initiated after approval by the responsible Ethics Committee of the Medical Faculty of the University of Heidelberg (\u201cFederf\u00fchrende Ethikkommission\u201d), all other ethics committees responsible for the study centers (\u201cBeteiligte Ethikkommissionen\u201d, the full list with names of all ethics committees can be found in Additional file), and the competent authority (The Federal Institute for Drugs and Medical Devices, BfArM). All study centers were initiated after approval obtained by the local ethics committees responsible for the participating study centers. The trial was registered in a clinical trial register before the first patient was recruited.For each participant in this clinical trial written informed consent is obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"914"}}